Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Eur Heart J
    June 2021
  1. VOLPE M, Patrono C
    A SPRINT towards tighter control of blood pressure in hypertension.
    Eur Heart J. 2021 Jun 25. pii: 6309731. doi: 10.1093.
    >> Share

  2. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    >> Share

  3. MESSERLI FH, Brguljan J, Rexhaj E, Sever P, et al
    Lowering systolic blood pressure to 120 mmHg or The Lancet's true grit.
    Eur Heart J. 2021;42:2052-2059.
    >> Share

  4. YAN Y, Mu J
    Salt intake paradox: the estimation method matters.
    Eur Heart J. 2021;42:2133.
    >> Share

    May 2021
  5. LANDMESSER U, Lehmann I, Eils R
    Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
    Eur Heart J. 2021;42:1720-1721.
    >> Share

    April 2021

  6. Erratum to: A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2021 Apr 13. pii: 6224359. doi: 10.1093.
    >> Share

    March 2021
  7. MANNUCCI PM, Ancona C
    Noise and air pollution as triggers of hypertension.
    Eur Heart J. 2021 Mar 22. pii: 6179518. doi: 10.1093.
    >> Share

  8. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    >> Share

    February 2021
  9. ESTRUCH R, Ruilope LM, Cosentino F
    The year in cardiovascular medicine 2020: epidemiology and prevention.
    Eur Heart J. 2021;42:813-821.
    >> Share

  10. WARTOLOWSKA KA, Webb AJS
    Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
    Eur Heart J. 2021;42:750-757.
    >> Share

    January 2021
  11. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    >> Share

    December 2020
  12. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics.
    Eur Heart J. 2020 Dec 28. pii: 6054230. doi: 10.1093.
    >> Share

  13. SALAH HM, Arthur JM, Mehta JL
    Implications of renal ACE2 expression in the age of COVID-19.
    Eur Heart J. 2020;41:4589-4591.
    >> Share

  14. CREA F
    Focus on hypertension but also on the 'the digital twin' and on kidney function and disease.
    Eur Heart J. 2020;41:4531-4534.
    >> Share

  15. LA GERCHE A
    Proof that exercise works, now it's time for optimizing delivery to our patients with pulmonary hypertension.
    Eur Heart J. 2020 Dec 12. pii: 6031923. doi: 10.1093.
    >> Share

    November 2020
  16. GRUNIG E, MacKenzie A, Peacock AJ, Eichstaedt CA, et al
    Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial.
    Eur Heart J. 2020 Nov 24. pii: 6000268. doi: 10.1093.
    >> Share


  17. Relates to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial' by Ramon C. Hermida et al. Eur Heart J 2020; https://doi.org/10.1093/eurheartj/ehz754.
    Eur Heart J. 2020 Nov 22. pii: 5998316. doi: 10.1093.
    >> Share

  18. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    >> Share

  19. GUO TT, Tan JS, Wu Y, Gao X, et al
    Balloon pulmonary angioplasty with distal embolic protection device for chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2020 Nov 12. pii: 5979515. doi: 10.1093.
    >> Share

  20. VOLPE M, Patrono C
    Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data.
    Eur Heart J. 2020;41:3986-3987.
    >> Share

    October 2020
  21. JIANG X, Eales JM, Scannali D, Nazgiewicz A, et al
    Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
    Eur Heart J. 2020 Oct 27. pii: 5940440. doi: 10.1093.
    >> Share

    September 2020
  22. VENKATA C, Ram S
    Dr Norman M. Kaplan (1931-2020): a giant in the field of hypertension has departed.
    Eur Heart J. 2020 Sep 25. pii: 5911422. doi: 10.1093.
    >> Share

    July 2020
  23. VOLPE M, Battistoni A
    Genes and hypertension: stepping into the secret through the arterial wall.
    Eur Heart J. 2020 Jul 29. pii: 5877875. doi: 10.1093.
    >> Share

  24. ESCANED J, Lerman LO
    Coronary microcirculation and hypertensive heart failure.
    Eur Heart J. 2020;41:2376-2378.
    >> Share

    June 2020
  25. ROMMEL KP, Lurz P
    Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
    Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
    >> Share

  26. D'ALTO M, Naeije R
    Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
    Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
    >> Share

  27. RUILOPE LM, Tamargo J, Ruiz-Hurtado G
    Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
    Eur Heart J. 2020 Jun 4. pii: 5851433. doi: 10.1093.
    >> Share

  28. GAO C, Cai Y, Zhang K, Zhou L, et al
    Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
    Eur Heart J. 2020 Jun 4. pii: 5851436. doi: 10.1093.
    >> Share

    May 2020
  29. ZHU WW, Lv XZ, Li WH
    Hereditary haemorrhagic telangiectasia with heritable pulmonary arterial hypertension.
    Eur Heart J. 2020 May 26. pii: 5846239. doi: 10.1093.
    >> Share

    April 2020
  30. KUSTER GM, Osswald S
    Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.
    Eur Heart J. 2020 Apr 23. pii: 5824224. doi: 10.1093.
    >> Share

  31. CIULLA MM
    Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19.
    Eur Heart J. 2020 Apr 23. pii: 5824223. doi: 10.1093.
    >> Share


  32. Relates to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial'.
    Eur Heart J. 2020;41:1600.
    >> Share

  33. LUSCHER TF
    Unanswered questions in hypertension: prematurity and long-term trajectories, masked and white coat hypertension.
    Eur Heart J. 2020;41:1527-1530.
    >> Share

  34. HERMIDA RC, Mojon A, Fernandez JR
    Comparing the design of the primary-care based Hygia Chronotherapy Trial and the Internet-Based TIME Study.
    Eur Heart J. 2020;41:1608.
    >> Share

  35. HERMIDA RC, Crespo JJ, Dominguez-Sardina M
    Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies.
    Eur Heart J. 2020;41:1602-1603.
    >> Share

  36. KELM M
    Early birth affects vascular function.
    Eur Heart J. 2020;41:1551-1553.
    >> Share

  37. GUTHRIE G, Poulter N, Macdonald T, Ford I, et al
    Chronotherapy in hypertension: the devil is in the details.
    Eur Heart J. 2020 Apr 19. pii: 5822566. doi: 10.1093.
    >> Share

  38. SANCHEZ-SANCHEZ C, Lopez-Caballero C, Contreras I, Puerto B, et al
    Is bedtime treatment appropriate for all hypertensive patients?
    Eur Heart J. 2020 Apr 18. pii: 5822039. doi: 10.1093.
    >> Share

  39. HERMIDA RC, Fernandez JR, Mojon A
    Chronotherapy of hypertension, asleep ambulatory blood pressure, and glaucoma.
    Eur Heart J. 2020 Apr 18. pii: 5822040. doi: 10.1093.
    >> Share

  40. SEN S, Kaskal M, Uresin Y
    Chrono-pharmacological effects of antihypertensive drugs.
    Eur Heart J. 2020 Apr 16. pii: 5820905. doi: 10.1093.
    >> Share

  41. LARSON S, Cho MC, Tsioufis K, Yang E, et al
    2018 Korean Society of Hypertension Guidelinefor the Management of Hypertension: A Comparison of American, European, and Korean Blood Pressure Guidelines.
    Eur Heart J. 2020;41:1384-1386.
    >> Share

    March 2020
  42. ZHOU W, Brown JM, Bajaj NS, Chandra A, et al
    Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.
    Eur Heart J. 2020 Mar 28. pii: 5813079. doi: 10.1093.
    >> Share

  43. MAHFOUD F, Azizi M, Ewen S, Pathak A, et al
    Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
    Eur Heart J. 2020 Mar 25. pii: 5811617. doi: 10.1093.
    >> Share

  44. LURZ P, Orban M, Besler C, Braun D, et al
    Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.
    Eur Heart J. 2020 Mar 16. pii: 5807655. doi: 10.1093.
    >> Share

  45. YAMASAKI Y, Abe K, Hosokawa K, Kamitani T, et al
    A novel pulmonary circulation imaging using dynamic digital radiography for chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2020 Mar 10. pii: 5802607. doi: 10.1093.
    >> Share

  46. JACOBSEN AP, Al Rifai M, Arps K, Whelton SP, et al
    A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2020 Mar 2. pii: 6157020. doi: 10.1093.
    >> Share

  47. COCA A
    Blood pressure and cardiovascular disease: are diastolic values 80-89 mmHg enough to define hypertension?
    Eur Heart J. 2020 Mar 2. pii: 6157019. doi: 10.1093.
    >> Share

  48. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    >> Share

    February 2020
  49. CHEN J, Guo J, Cao S
    Unexplained pulmonary hypertension: an overlooked aortopulmonary window.
    Eur Heart J. 2020 Feb 8. pii: 5731317. doi: 10.1093.
    >> Share

    January 2020
  50. ZHOU Y, Wen J, Nie J
    How much can acute heart failure patients with low basic blood pressure (systolic blood pressure 90-100 mmHg) benefit from the use of vasodilators?
    Eur Heart J. 2020 Jan 10. pii: 5700445. doi: 10.1093.
    >> Share

    December 2019
  51. CRUMP C, Sundquist J, Sundquist K
    Risk of hypertension into adulthood in persons born prematurely: a national cohort study.
    Eur Heart J. 2019 Dec 23. pii: 5686008. doi: 10.1093.
    >> Share

    November 2019
  52. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    >> Share

  53. MATHUR P, Kadavath S, Marsh JD, Mehta JL, et al
    Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs.
    Eur Heart J. 2019 Nov 14. pii: 5625542. doi: 10.1093.
    >> Share

    October 2019
  54. HERMIDA RC, Crespo JJ, Dominguez-Sardina M, Otero A, et al
    Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
    Eur Heart J. 2019 Oct 22. pii: 5602478. doi: 10.1093.
    >> Share

  55. MCCORMACK T, Boffa RJ, Jones NR, Carville S, et al
    The 2018 ESC/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ.
    Eur Heart J. 2019 Oct 7. pii: 5583202. doi: 10.1093.
    >> Share

  56. SCHIFFRIN EL, Engert JC
    Periodontitis and hypertension: causally linked by immune mechanisms.
    Eur Heart J. 2019 Oct 7. pii: 5582717. doi: 10.1093.
    >> Share

  57. KJELDSEN SE, Os I
    Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH.
    Eur Heart J. 2019 Oct 3. pii: 5580654. doi: 10.1093.
    >> Share

    September 2019
  58. OBOKATA M, Kane GC, Reddy YNV, Melenovsky V, et al
    The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
    Eur Heart J. 2019 Sep 12. pii: 5568303. doi: 10.1093.
    >> Share

  59. CZESNIKIEWICZ-GUZIK M, Osmenda G, Siedlinski M, Nosalski R, et al
    Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy.
    Eur Heart J. 2019 Sep 1. pii: 5556904. doi: 10.1093.
    >> Share

    August 2019
  60. HERMIDA RC
    Treatment of sleep-disordered breathing, alone, is insufficient for proper management of sleep-time hypertension.
    Eur Heart J. 2019 Aug 29. pii: 5556424. doi: 10.1093.
    >> Share

  61. MEDIANO O, Sanchez-de-la-Torre M, Garcia-Rio F
    The role of sleep disorders breathing treatment as a modifiable condition for cardiovascular risk associated hypertension.
    Eur Heart J. 2019 Aug 29. pii: 5556423. doi: 10.1093.
    >> Share

  62. MANIERO C, Gupta AK, Lobo MD
    Impact of the New ACC/AHA and ESC/ESH Hypertension Guidelines in the UK.
    Eur Heart J. 2019;40:2472-2475.
    >> Share

    July 2019
  63. TIWANA J, Yang E
    Clinical Implications of the 2017 ACC/AHA Hypertension Guidelines.
    Eur Heart J. 2019;40:2106-2109.
    >> Share

    June 2019
  64. KANDZARI DE
    Renal denervation for hypertension: what is needed, and what is next.
    Eur Heart J. 2019 Jun 15. pii: 5519362. doi: 10.1093.
    >> Share

  65. EMRICH IE, Bohm M, Mahfoud F
    The 2018 ESC/ESH Guidelines for the management of arterial hypertension: A German point of view.
    Eur Heart J. 2019;40:1830-1831.
    >> Share

  66. GENTILLE LORENTE DI
    Coconut atrium: a rare entity to cause pulmonary hypertension.
    Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
    >> Share

    May 2019
  67. KJELDSEN SE, Aksnes TA, Mo R, Klemsdal TO, et al
    Impact of the New ACC/AHA and ESC/ESH Hypertension Guidelines for Norway.
    Eur Heart J. 2019;40:1485-1487.
    >> Share

  68. SHARASHOVA E, Wilsgaard T, Ball J, Morseth B, et al
    Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromso Study.
    Eur Heart J. 2019 May 3. pii: 5485289. doi: 10.1093.
    >> Share

  69. BEANEY T, Burrell LM, Castillo RR, Charchar FJ, et al
    May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.
    Eur Heart J. 2019 May 1. pii: 5481538. doi: 10.1093.
    >> Share

    April 2019
  70. HAEUSLER KG, Huttner HB, Kuramatsu JB
    Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension.
    Eur Heart J. 2019 Apr 21. pii: 5475829. doi: 10.1093.
    >> Share

  71. COCA PAYERAS A, Williams B, Mancia G
    Response to 'Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension'.
    Eur Heart J. 2019 Apr 21. pii: 5475833. doi: 10.1093.
    >> Share

    March 2019
  72. MORALES-SALINAS A, Kones R
    Concerning the degradation of beta-blocker use in the 2018 ESC/ESH hypertension guidelines.
    Eur Heart J. 2019 Mar 14. pii: 5381105. doi: 10.1093.
    >> Share

  73. FEITOSA ADM, Mota-Gomes MA, Nadruz W
    How should treated hypertensive patients with systolic blood pressure below 120 mmHg be managed?
    Eur Heart J. 2019 Mar 11. pii: 5374729. doi: 10.1093.
    >> Share

  74. HU C
    C-type Hypertension.
    Eur Heart J. 2019;40:715.
    >> Share

    February 2019
  75. ESLER M
    Does increased 24-h ambulatory heart rate identify de facto neurogenic hypertension, and facilitate selection of hypertensive patients for renal denervation?
    Eur Heart J. 2019 Feb 7. pii: 5309047. doi: 10.1093.
    >> Share

    January 2019
  76. CZOPEK A, Moorhouse R, Guyonnet L, Farrah T, et al
    A novel role for myeloid endothelin-B receptors in hypertension.
    Eur Heart J. 2019 Jan 17. pii: 5289586. doi: 10.1093.
    >> Share

  77. SCHIFFRIN EL
    New blood pressure cut-offs, prevalence of hypertension and control, and mood disorders: are patients benefitting from lower cut-offs for defining hypertension?
    Eur Heart J. 2019 Jan 8. pii: 5280831. doi: 10.1093.
    >> Share

  78. KIM TH, Yang PS, Yu HT, Jang E, et al
    Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population.
    Eur Heart J. 2019 Jan 4. pii: 5273478. doi: 10.1093.
    >> Share

  79. BOHM M, Mahfoud F, Townsend RR, Kandzari DE, et al
    Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Eur Heart J. 2019 Jan 4. pii: 5273473. doi: 10.1093.
    >> Share

  80. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Eur Heart J. 2019 Jan 2. pii: 5272355. doi: 10.1093.
    >> Share

    December 2018
  81. CASELLI S, Serdoz A, Mango F, Lemme E, et al
    High blood pressure response to exercise predicts future development of hypertension in young athletes.
    Eur Heart J. 2018 Dec 22. pii: 5255629. doi: 10.1093.
    >> Share

  82. LUSCHER TF
    Arterial and pulmonary hypertension: risk assessment and current pharmacological and interventional management.
    Eur Heart J. 2018;39:4127-4131.
    >> Share

  83. ESLER M
    Renal nerve ablation for hypertension: Update from an insider.
    Eur Heart J. 2018;39:4054-4055.
    >> Share

  84. OZKAN J
    Thomas Luscher on the revival of renal nerve ablation for hypertension.
    Eur Heart J. 2018;39:4053-4054.
    >> Share

    November 2018
  85. KLOK FA, Pruefer D, Rolf A, Konstantinides SV, et al
    Magnetic resonance direct thrombus imaging for pre-operative assessment of acute thrombosis in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2018 Nov 27. pii: 5211203. doi: 10.1093.
    >> Share

  86. ATASOY S, Johar H, Peters A, Ladwig KH, et al
    Association of hypertension cut-off values with 10-year cardiovascular mortality and clinical consequences: a real-world perspective from the prospective MONICA/KORA study.
    Eur Heart J. 2018 Nov 21. pii: 5195184. doi: 10.1093.
    >> Share

  87. TSIOUFIS K, Kreutz R
    ESH Annual Meeting 2018: Reinhold Kreutz reports on the 28th European Meeting on Hypertension and Cardiovascular Protection that took place in Barcelona, Spain, 8-11 June.
    Eur Heart J. 2018;39:3836-3839.
    >> Share

    September 2018
  88. GIANNONI A, Masi S
    Arterial hypertension and the turbulent ageing of the aortic valve.
    Eur Heart J. 2018 Sep 12. pii: 5094939. doi: 10.1093.
    >> Share

  89. RAHIMI K, Mohseni H, Kiran A, Tran J, et al
    Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults.
    Eur Heart J. 2018 Sep 12. pii: 5094940. doi: 10.1093.
    >> Share

  90. ESHAK N, Abdelnaby M, Shehata H, Ziada K, et al
    A case of fibrosing mediastinitis complicated by pulmonary hypertension and right-sided heart failure.
    Eur Heart J. 2018 Sep 7. pii: 5092489. doi: 10.1093.
    >> Share

  91. ZHAO ZG, Xu YN, Chen M, Feng Y, et al
    Isolated intracranial arterial hypertension.
    Eur Heart J. 2018 Sep 5. pii: 5091011. doi: 10.1093.
    >> Share

    August 2018
  92. WILLIAMS B, Mancia G, Spiering W, Agabiti Rosei E, et al
    2018 ESC/ESH Guidelines for the management of arterial hypertension.
    Eur Heart J. 2018 Aug 25. pii: 5079119. doi: 10.1093.
    >> Share

  93. VIDAL-PETIOT E, Elbez Y, Luscher TF, Fox KM, et al
    The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients.
    Eur Heart J. 2018 Aug 25. pii: 5077828. doi: 10.1093.
    >> Share

  94. NIEBAUER J, Borjesson M, Carre F, Caselli S, et al
    Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC).
    Eur Heart J. 2018 Aug 24. pii: 5079290. doi: 10.1093.
    >> Share

  95. ALI WE, Bakris GL
    Initial single-pill combinations for antihypertensive treatment: greater cardiovascular mortality reduction yet still not used.
    Eur Heart J. 2018 Aug 21. pii: 5077319. doi: 10.1093.
    >> Share

    July 2018
  96. REA F, Corrao G, Merlino L, Mancia G, et al
    Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension.
    Eur Heart J. 2018 Jul 27. pii: 5060560. doi: 10.1093.
    >> Share

  97. PETERS R, Anstey KJ, Booth A, Beckett N, et al
    Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort.
    Eur Heart J. 2018 Jul 24. pii: 5058115. doi: 10.1093.
    >> Share

  98. DIENER HC
    Preventing dementia beyond treating hypertension.
    Eur Heart J. 2018 Jul 20. pii: 5056853. doi: 10.1093.
    >> Share

    June 2018
  99. AUER J, Sharman JE, Weber T
    J-curves in hypertension: what do they tell us about treatment of high blood pressure?
    Eur Heart J. 2018 Jun 13. pii: 5037239. doi: 10.1093.
    >> Share

  100. ABELL JG, Kivimaki M, Dugravot A, Tabak AG, et al
    Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension.
    Eur Heart J. 2018 Jun 12. pii: 5032485. doi: 10.1093.
    >> Share

    March 2018
  101. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    >> Share

  102. BURNIER M
    Hypertension Guidelines.
    Eur Heart J. 2018;39:908-910.
    >> Share

  103. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    >> Share

    January 2018
  104. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    >> Share

  105. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
    Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
    >> Share

  106. MESSERLI FH, Rimoldi SF, Bangalore S
    Changing definition of hypertension in guidelines: how innocent a number game?
    Eur Heart J. 2018 Jan 9. pii: 4794716. doi: 10.1093.
    >> Share

    December 2017
  107. GALIE N, Manes A, Dardi F, Palazzini M, et al
    Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease.
    Eur Heart J. 2017 Dec 27. pii: 4780182. doi: 10.1093.
    >> Share

  108. BERMEJO J, Yotti R, Garcia-Orta R, Sanchez-Fernandez PL, et al
    Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
    Eur Heart J. 2017 Dec 21. pii: 4769387. doi: 10.1093.
    >> Share

    November 2017
  109. LUSCHER TF
    From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values.
    Eur Heart J. 2017;38:3258-3271.
    >> Share

    October 2017
  110. RUIZ-HURTADO G, Ruilope LM
    Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.
    Eur Heart J. 2017 Oct 20. doi: 10.1093.
    >> Share

  111. LUSCHER TF
    Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles.
    Eur Heart J. 2017;38:2857-2859.
    >> Share

  112. BANGALORE S, Schwamm L, Smith EE, Hellkamp AS, et al
    Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke.
    Eur Heart J. 2017;38:2827-2835.
    >> Share

    September 2017
  113. SCHMIEDER RE, Wagner F, Mayr M, Delles C, et al
    The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    Eur Heart J. 2017 Sep 27. doi: 10.1093.
    >> Share

  114. AOKI T, Sugimura K, Tatebe S, Miura M, et al
    Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications.
    Eur Heart J. 2017 Sep 23. doi: 10.1093.
    >> Share

  115. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    >> Share

    August 2017
  116. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    >> Share

    June 2017
  117. WEATHERALD J, Sitbon O, Humbert M
    Validation of a risk assessment instrument for pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    >> Share

  118. KYLHAMMAR D, Kjellstrom B, Hjalmarsson C, Jansson K, et al
    A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 1. doi: 10.1093.
    >> Share

    May 2017
  119. PATEL RS, Masi S, Taddei S
    Understanding the role of genetics in hypertension.
    Eur Heart J. 2017 May 25. doi: 10.1093.
    >> Share

  120. MAHFOUD F, Schmieder RE, Azizi M, Pathak A, et al
    Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    >> Share

    April 2017
  121. NIIRANEN TJ, McCabe EL, Larson MG, Henglin M, et al
    Risk for hypertension crosses generations in the community: a multi-generational cohort study.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    >> Share

  122. LUSCHER TF
    From systemic and pulmonary hypertension to heart failure: novel drugs and devices.
    Eur Heart J. 2017;38:1087-1090.
    >> Share

  123. FUKS KB, Weinmayr G, Basagana X, Gruzieva O, et al
    Long-term exposure to ambient air pollution and traffic noise and incident hypertension in seven cohorts of the European study of cohorts for air pollution effects (ESCAPE).
    Eur Heart J. 2017;38:983-990.
    >> Share

    March 2017
  124. VAN EMPEL V, Knackstedt C, van Paassen P, Brunner-La Rocca HP, et al
    Just air good enough in pulmonary hypertension?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    >> Share

  125. ULRICH S, Hasler ED, Saxer S, Furian M, et al
    Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.
    Eur Heart J. 2017 Mar 11. doi: 10.1093.
    >> Share

  126. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    >> Share

    February 2017
  127. GALIE N, Jansa P, Pulido T, Channick RN, et al
    SERAPHIN haemodynamic sub-study: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Eur Heart J. 2017 Feb 28. doi: 10.1093.
    >> Share

  128. VAN DER FEEN DE, Bartelds B, de Boer RA, Berger RM, et al
    Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.
    Eur Heart J. 2017 Feb 23. doi: 10.1093.
    >> Share

  129. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    >> Share

    January 2017
  130. MAGGIONI AP, Ruschitzka F
    The year in cardiology 2016: heart failure.
    Eur Heart J. 2017 Jan 2. pii: ehw638. doi: 10.1093.
    >> Share

    May 2016
  131. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    >> Share

    February 2016
  132. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016